Skip to content

The effect of a centella asiatica containing repair mask as an adjuvant and preventive treatment for rosacea

The effect of a centella asiatica containing repair mask as an adjuvant and preventive treatment for rosacea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026527
Enrollment
Unknown
Registered
2019-10-13
Start date
2019-10-14
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Treatment group(T1):Minocycline 50mg bid+base bid+centella asiatica containing repair mask tiw
Control group(C1):Minocycline 50mg bid+base bid
Treatment group(T2):Centella asiatica containing repair mask+base, tiw

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University Medical School
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Meet the clinical diagnosis criteria of rosacea; rosacea score IGA >=3 points; 2. Women, between 25-55 years old; 3. Subjects should fully understand the content of trial, be willing to participate in the trial, and have signed an informed consent form; 4. No previous cosmetic adverse reactions reported; 5. Subjects are accustomed or have a desire to use a mask; 6. Physical examination revealed no abnormality, no history of serious cardiac, hepatic, renal, digestive, neurologic, psychiatric and metabolic disease; 7. No drug was taken during 1 month before treatment; no antibiotics were used topically in the past 1 week.

Exclusion criteria

Exclusion criteria: 1. The subject dose not meet the physical examination in inclusion criteria; 2. Pregnant, lactating women; 3. Be allergic to the ingredients or excipients of the trial drug; 4. Participated in any other clinical investigation within three months before the beginning of this trial; 5. Frequent user of Chinese herbal medicines, sleeping pills, sedatives, tranquilizers, or other addictive drugs; 6. Alcoholics, mental patients; or the subject can not follow doctor's advice; 7. Suffering from cardiopulmonary insufficiency or severe underlying diseases; 8. Suffering from other skin conditions that may interfere with the clinical assessment of acneiform skin evaluation and/or pose a risk to the subject, or have other serious skin disease history; 9. The investigator thinks that there are other reasons to exclude the subject in this trial.

Design outcomes

Primary

MeasureTime frame
Visia CR;TEWL;Corneometer;Rosacea IGA;Lesion index;SSRI;Redness score;Dryness score;Desquamation score;Acne-QOL;Sensitivity scale;Comfortableness;

Secondary

MeasureTime frame
skin temperature;Sebumeter;skin pH;a value;melanin;redness;

Countries

China

Contacts

Public ContactJie Zheng

Ruijin Hospital, Shanghai Jiao Tong University Medical School

jie-zheng2001@126.com+86 18917762309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026